Laboratories Ojer Pharma SL:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Laboratories Ojer Pharma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10586
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Laboratories Ojer Pharma SL (Ojer Pharma) is a developer of pharmaceutical products in dermatology. The company’s products categories include prescription medicine, over the counter OTC, medical devices and cosmetic products. It offers products such as previderm, dermatul nasal, dermatul lipogel, lipovir gel and dermatul queratosis, among others. Ojer Pharma’s products find application for the treatment of diseases such as dermatitis, ulcerations, infections and wound care protection, among others. The company conducts research and development activities for the treatment of dermatological diseases. It works in partnership with other universities and research institutes. Ojer Pharma is headquartered in Pamplona, Spain.

Laboratories Ojer Pharma SL – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Laboratories Ojer Pharma Raises USD0.8 Million in Venture Financing 10
Partnerships 11
Laboratories Ojer Pharma, College of Pharmacy of the University of Barcelona and Tecnalia Enter into Co-Development Agreement 11
Reig Jofre Enters Into Co-Development Agreement With Ojer Pharma For Nobactine 12
Laboratories Ojer Pharma SL – Key Competitors 13
Laboratories Ojer Pharma SL – Key Employees 14
Laboratories Ojer Pharma SL – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Key Facts 2
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratories Ojer Pharma SL, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Laboratories Ojer Pharma Raises USD0.8 Million in Venture Financing 10
Laboratories Ojer Pharma, College of Pharmacy of the University of Barcelona and Tecnalia Enter into Co-Development Agreement 11
Reig Jofre Enters Into Co-Development Agreement With Ojer Pharma For Nobactine 12
Laboratories Ojer Pharma SL, Key Competitors 13
Laboratories Ojer Pharma SL, Key Employees 14

List of Figures
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratories Ojer Pharma SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Laboratories Ojer Pharma SL:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Caldera Health Ltd:企業の製品パイプライン分析2018
    Summary Caldera Health Ltd (Caldera) is a biotech company that develops prostate cancer diagnostic tools. The company offers prostate cancer diagnostic and prognostic tests to detect and monitor the cancer disease. It has developed a laboratory test that measures the expression of a range of RNA bio …
  • Les Laboratoires Servier:企業の戦略・SWOT・財務分析
    Les Laboratoires Servier - Strategy, SWOT and Corporate Finance Report Summary Les Laboratoires Servier - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Boone Electric Cooperative:企業の発電所・SWOT分析2018
    Boone Electric Cooperative - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Mahindra & Mahindra Financial Services Limited:企業のM&A・事業提携・投資動向
    Mahindra & Mahindra Financial Services Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mahindra & Mahindra Financial Services Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descriptio …
  • Companhia Riograndense de Mineracao:企業の戦略・SWOT・財務情報
    Companhia Riograndense de Mineracao - Strategy, SWOT and Corporate Finance Report Summary Companhia Riograndense de Mineracao - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • MEG Energy Corp (MEG):石油・ガス:M&Aディール及び事業提携情報
    Summary MEG Energy Corp (MEG) is an oil and gas company that develops and produces from oil sands. The company operates Christina lake, May River and Surmont project. Its technologies comprise steam-assisted gravity drainage, cogeneration, Hi-Q field pilot and eMSAGP. MEG's Christina Lake project is …
  • Bactiguard Holding AB (BACTI B):医療機器:M&Aディール及び事業提携情報
    Summary Bactiguard Holding AB (Bactiguard) is a medical device manufacturer which develops and supplies infection protection solutions and antibiotics. The company’s product portfolio includes urinary catheters, foley catheters (BIP Foley catheters), endotracheal tubes and central venous catheters. …
  • KLM Catering Services Schiphol bv:企業の戦略・SWOT・財務分析
    KLM Catering Services Schiphol bv - Strategy, SWOT and Corporate Finance Report Summary KLM Catering Services Schiphol bv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Audentes Therapeutics Inc (BOLD):製薬・医療:M&Aディール及び事業提携情報
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for serious and life-threatening rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myop …
  • Immatics Biotechnologies GmbH:企業のM&A・事業提携・投資動向
    Immatics Biotechnologies GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Immatics Biotechnologies GmbH Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Horiba Ltd (6856):企業の財務・戦略的SWOT分析
    Summary Horiba Ltd (Horiba) is a manufacturer of precision instruments and systems. The company's product portfolio includes automotive mechatronics, emission measurement systems, test systems, in vitro diagnostic systems, gas and oxygen analyzers, monitoring devices, industrial conductivity meters, …
  • Pratt Industries Inc:戦略・SWOT・企業財務分析
    Pratt Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Pratt Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Sypris Solutions Inc (SYPR):企業の財務・戦略的SWOT分析
    Sypris Solutions Inc (SYPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • General Motors Company:企業の戦略・SWOT・財務分析
    General Motors Company - Strategy, SWOT and Corporate Finance Report Summary General Motors Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Pacific Gas and Electric Co-石油・ガス分野:企業M&A・提携分析
    Summary Pacific Gas and Electric Company (PGEC), a subsidiary of PG&E Corporation, is an energy utility, offering electricity and natural gas to its customers. The company carries out generation, transmission and distribution of electricity. PGEC serves residential, commercial, industrial and agricu …
  • Palred Technologies Limited:戦略・SWOT・企業財務分析
    Palred Technologies Limited - Strategy, SWOT and Corporate Finance Report Summary Palred Technologies Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • H.I.S. Co., Ltd.:企業の戦略・SWOT・財務情報
    H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • SRCTec, Inc.:企業の戦略・SWOT・財務情報
    SRCTec, Inc. - Strategy, SWOT and Corporate Finance Report Summary SRCTec, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Sime Darby Bhd (SIME):企業の財務・戦略的SWOT分析
    Sime Darby Bhd (SIME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bridgford Foods Corporation:企業の戦略・SWOT・財務分析
    Bridgford Foods Corporation - Strategy, SWOT and Corporate Finance Report Summary Bridgford Foods Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆